扫 描 看 全 文
.脑胶质瘤中西医结合临床诊疗专家共识(上海)[J].上海中医药大学学报,2023,37(05):1-10.
.Expert consensus on integrated traditional Chinese and western medicine clinical diagnosis and treatment of brain glioma (Shanghai)[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(05):1-10.
.脑胶质瘤中西医结合临床诊疗专家共识(上海)[J].上海中医药大学学报,2023,37(05):1-10. DOI: 10.16306/j.1008-861x.2023.05.001.
.Expert consensus on integrated traditional Chinese and western medicine clinical diagnosis and treatment of brain glioma (Shanghai)[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(05):1-10. DOI: 10.16306/j.1008-861x.2023.05.001.
脑胶质瘤是一种起源于脑胶质细胞的颅内恶性肿瘤,其常规治疗方案为最大安全范围内的手术切除,术后放疗联合替莫唑胺并辅助替莫唑胺化疗,亦可辅助电场治疗,但临床治疗效果仍不理想。为充分发挥中医药在脑胶质瘤治疗中的作用、延长患者的生存期,上海市中西医结合学会神经外科专业委员会组织相关专家,通过查阅文献及参考名中医临床经验,就脑胶质瘤的西医诊断与分类、中医辨证论治、西医治疗等达成专家共识,以期为脑胶质瘤的临床诊疗提供依据。
Brain glioma is an intracranial malignant tumor originating from glial cells. The conventional therapeutic regimen is surgical resection within the maximum safe range, postoperative radiotherapy combined with temozolomide and adjuvant temozolomide for chemotherapy, or adjuvant electric field therapy. However, the clinical effect is still not ideal. In order to fully play the role of traditional Chinese medicine in the treatment of brain glioma and prolong the survival period of patients, Neurosurgery Professional Committee of Shanghai Association of Chinese Integrative Medicine organized relevant domestic experts to reach an expert consensus on the diagnosis and classification of western medicine, differentiation and treatment of traditional Chinese medicine, and western medical treatment of brain glioma by consulting relevant literatures and referring to the clinical experiences of famous doctors of traditional Chinese medicine. The aim is to provide a reference for the clinical diagnosis and treatment of brain glioma.
脑胶质瘤中西医结合诊疗专家共识上海
brain gliomaintegrated traditional Chinese and western medicinediagnosis and treatmentexpert consensusShanghai
CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
国家卫生健康委员会医政医管局. 脑胶质瘤诊疗规范(2018年版)[J]. 中华神经外科杂志, 2019, 35(3): 217-239.
Medical Administration Bureau of National Health Commission Diagnostic and Treatment Guidelines for Brain Glioma (2018 Edition)[J]. Chinese Journal of Neurosurgery, 2019, 35(3): 217-239.
程孟祺, 秦英刚, 姜菊玲, 等. 中医药治疗脑胶质瘤临床研究进展[J]. 辽宁中医药大学学报, 2020, 22(12): 147-151.
CHENG M Q, QIN Y G, JIANG J L, et al. Clinical Research Progress of Traditional Chinese Medicine in the Treatment of Glioma[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(12): 147-151.
JIANG T, NAM D H, RAM Z, et al. Clinical practice guidelines for the management of adult diffuse gliomas[J]. Cancer Lett, 2021, 499: 60-72.
LIANG S, FAN X, ZHAO M, et al. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy[J]. Cancer Med, 2019, 8(10): 4527-4535.
中国抗癌协会脑胶质瘤专业委员会. 中国抗癌协会脑胶质瘤整合诊治指南(精简版)[J]. 中国肿瘤临床, 2022, 49(16): 811-818.
Brain Glioma Professional Committee of Chinese Anti-Cancer Association. China Anti-Cancer Association guidelines for integrative diagnosis and treatment of glioma (abridged version)[J]. Chinese Journal of Clinical Oncology, 2022, 49(16): 811-818.
LOUIS D N, PERRY A, WESSELING P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary[J]. Neuro Oncol, 2021, 23(8): 1231-1251.
LOUIS D N, WESSELING P, PAULUS W, et al. cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)[J]. Acta Neuropathol, 2018, 135(3): 481-484.
ELLISON D W, HAWKINS C, JONES D T W, et al. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation[J]. Acta Neuropathol, 2019, 137(4): 683-687.
LOUIS D N, WESSELING P, ALDAPE K, et al. cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading[J]. Brain Pathol, 2020, 30(4): 844-856.
《中国中枢神经系统胶质瘤诊断和治疗指南》编写组. 中国中枢神经系统胶质瘤诊断与治疗指南(2015)[J]. 中华医学杂志, 2016, 96(7): 485-509.
Compilation group of Guidelines for the Diagnosis and Treatment of Glioma in the Central Nervous System of China. Guidelines for the Diagnosis and Treatment of Glioma in the Central Nervous System of China (2015)[J]. National Medical Journal of China, 2016, 96(7): 485-509.
HU H, MU Q, BAO Z, et al. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor[J]. Cell, 2018, 175(6): 1665-1678.
DUNET V, POMONI A, HOTTINGER A, et al. Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis[J]. Neuro Oncol, 2016, 18(3): 426-434.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构